Canlyniadau Chwilio - Jason Gotlib

Mireinio'r Canlyniadau
  1. 1
    Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation

    Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation gan Jason Gotlib

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    How I treat atypical chronic myeloid leukemia

    How I treat atypical chronic myeloid leukemia gan Jason Gotlib

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management gan Jason Gotlib

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    World Health Organization‐defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management gan Jason Gotlib

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management gan Jason Gotlib

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    World Health Organization‐defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management gan Jason Gotlib

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Myeloid neoplasms with eosinophilia

    Myeloid neoplasms with eosinophilia gan Andreas Reiter, Jason Gotlib

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management gan William Shomali, Jason Gotlib

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management gan William Shomali, Jason Gotlib

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management

    World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management gan William Shomali, Jason Gotlib

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update

    Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update gan Ayalew Tefferi, Jason Gotlib, Animesh Pardanani

    Cyhoeddwyd 2010
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis gan Andreas Reiter, Tracy I. George, Jason Gotlib

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment

    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment gan Jason Gotlib, Julia E. Maxson, Tracy I. George, Jeffrey W. Tyner

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management

    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management gan Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

    Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations gan Robert S. Ohgami, Lisa Ma, Jason D. Merker, Jason Gotlib, Iris Schrijver, James L. Zehnder, Daniel A. Arber

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i>

    Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i> gan Massa J. Shoura, Idan Gabdank, Loren Hansen, Jason D. Merker, Jason Gotlib, Stephen D. Levene, Andrew Fire

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    The serum tryptase test: an emerging robust biomarker in clinical hematology

    The serum tryptase test: an emerging robust biomarker in clinical hematology gan Peter Valent, Wolfgang R. Sperr, Karl Sotlar, Andreas Reiter, Cem Akin, Jason Gotlib, Hans-Peter Horny, Michel Arock

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Treatment advances have not improved the early death rate in acute promyelocytic leukemia

    Treatment advances have not improved the early death rate in acute promyelocytic leukemia gan James Scott McClellan, Holbrook E. Kohrt, Steven Coutré, Jason Gotlib, Ravindra Majeti, Ash A. Alizadeh, Bruno C. Medeiros

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.

    Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. gan William Wallace, Stephen T. Ahlers, Jason Gotlib, Valentin Bragin, J. Sugár, R Gluck, Paul Shea, Keith L. Davis, Vahram Haroutunian

    Cyhoeddwyd 1993
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I

    Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I gan Ruben A. Mesa, Srđan Verstovšek, Vikas Gupta, John Mascarenhas, Ehab Atallah, Timothy C. Burn, William Sun, Victor Sandor, Jason Gotlib

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: